Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03823209 · ClinicalTrials.gov registry record · NA
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
A NA study of Human Immunodeficiency Virus, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT03823209: Active NA study of Human Immunodeficiency Virus, sponsored by Medical College of Wisconsin.
NCT03823209 is a NA study of Human Immunodeficiency Virus that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 500 participants, above the 171-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (192% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03823209, a NA study of Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the use of a social-network approach to encourage African-American men who have sex with men (AAMSM) to adopt pre-exposure prophylaxis (PrEP) to prevent HIV infection. Thirty-six networks of AAMSM will be recruited in Milwaukee, WI, and Cleveland, OH. Half of these networks will have their leaders trained to endorse PrEP to their social network members, and the other half will be given brief HIV prevention counseling.
Primary Outcome
Change in self-reported PrEP use
Conditions Studied
Interventions
- BEHAVIORAL Social Network
- BEHAVIORAL Brief HIV Prevention Counseling
Study Locations (2)
Ohio
- AIDS TaskForce of Greater Cleveland - Cleveland
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-01-24 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What the registry record for NCT03823209 still lists
NCT03823209 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 171-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (192% higher).
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 2 interventions - of which Social Network is the first listed.
NCT03823209 reports a single indexed study location in Ohio, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03823209 about?
NCT03823209 is a clinical study titled "Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities". This study evaluates the use of a social-network approach to encourage African-American men who have sex with men (AAMSM) to adopt pre-exposure prophylaxis (PrEP) to prevent HIV infection. Thirty-six networks of AAMSM will be recruited in Milwaukee, WI, and Cleveland, OH. Half of these networks will...
What is the current status of trial NCT03823209?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2019-01-24. Estimated completion is 2025-12-01.
What conditions does trial NCT03823209 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT03823209?
The interventions under investigation include: Social Network (BEHAVIORAL), Brief HIV Prevention Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03823209?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03823209 being conducted?
This trial has 2 study locations across Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03823209's enrollment target sits among peer trials
500 5th of 39 higher than 35 of 39 other Human Immunodeficiency Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Immunodeficiency Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
-
CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI